Schizophrenia Research
Volume 116, Issue 1 , Pages 68-74 , January 2010

Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese

  • San-Yuan Huang

      Affiliations

    • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Tri-Service General Hospital, No. 325, Sec. 2, Cheng-Kung Road, Nei-Hu District, Taipei, 114, Taiwan, ROC. Tel.: +011 886 2 8792 7220; fax: +011 886 2 8792 6715.
    • ,
  • Hsing-Kang Chen

      Affiliations

    • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
    • General Psychiatric department, Yu-Li Hospital, Hualien, Taiwan, ROC
    • ,
  • Kuo-Hsing Ma

      Affiliations

    • Department of Anatomy and Biology, National Defense Medical Center, Taipei, Taiwan, ROC
    • ,
  • Mee-Jen Shy

      Affiliations

    • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
    • Department of Anatomy and Biology, National Defense Medical Center, Taipei, Taiwan, ROC
    • ,
  • Jiun-Hsiung Chen

      Affiliations

    • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
    • Division of Psychiatry, GangShan Armed Forces Hospital, Kaohsiung, Taiwan, ROC
    • ,
  • Wen-chi Lin

      Affiliations

    • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
    • Department of Nursing, Tri-Service General Hospital, Taipei, Taiwan, ROC
    • ,
  • Ru-Band Lu

      Affiliations

    • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
    • Institute of Behavioral Medicine, Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC

Received 25 September 2008 ,Revised 28 September 2009 ,Accepted 4 October 2009.

References 

  1. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265Oxford, England
  2. Birkett P, Sigmundsson T, Sharma T, Toulopoulou T, Griffiths TD, Reveley A, et al. Executive function and genetic predisposition to schizophrenia—the Maudsley family study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147:285–293
  3. Borowski TB, Kokkinidis L. The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis. Behav. Neurosci. 1998;112:952–965
  4. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U. S. A. 1997;94:2569–2574
  5. Buchner A, Faul F, Erdfelder E. G-power: A Priori, Post Hoc, and Compromise Power Analyses for the Macintosh, Version 2.1.1. Trier, Germany: University of Trier; 1996;
  6. Cardno AG, Thomas K, McGuffin P. Clinical variables and genetic loading for schizophrenia: analysis of published Danish adoption study data. Schizophr. Bull. 2002;28:393–399
  7. Carvelli L, Blakely RD, DeFelice LJ. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc. Natl. Acad. Sci. U. S. A. 2008;105:14,192–14,197
  8. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry. 1991;148:1474–1486
  9. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry. 1978;35:837–844
  10. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol. Psychiatry. 2005;10:6–13
  11. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225–2229New York, NY
  12. Gamma F, Faraone SV, Glatt SJ, Yeh YC, Tsuang MT. Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophr. Res. 2005;73:55–58
  13. Genro JP, Zeni C, Polanczyk GV, Roman T, Rohde LA, Hutz MH. A promoter polymorphism (−839 C>T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007;144:215–219
  14. Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 1993;14:43–49
  15. Goldstein M, Deutch AY. Dopaminergic mechanisms in the pathogenesis of schizophrenia. Faseb J. 1992;6:2413–2421
  16. Greenwood TA, Kelsoe JR. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics. 2003;82:511–520
  17. Haeffel GJ, Getchell M, Koposov RA, Yrigollen CM, Deyoung CG, Klinteberg BA, et al. Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychol. Sci. 2008;19:62–69
  18. Hjerde E, Dahl SG, Sylte I. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor. Eur. J. Med. Chem. 2005;40:185–194
  19. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch. Gen. Psychiatry. 2009;66:13–20
  20. Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, et al. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin. Exp. Res. 2004;28:374–384
  21. Huang SY, Lin WW, Wan FJ, Chang AJ, Ko HC, Wang TJ, et al. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J. Psychiatry Neurosci. 2007;32:185–192
  22. Kay SR, F.A. , Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  23. Keikhaee MR, Fadai F, Sargolzaee MR, Javanbakht A, Najmabadi H, Ohadi M. Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005;135:47–49
  24. Khodayari N, Garshasbi M, Fadai F, Rahimi A, Hafizi L, Ebrahimi A, et al. Association of the dopamine transporter gene (DAT1) core promoter polymorphism -67T variant with schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004;129:10–12
  25. Merikangas KR, Stevens DE, Fenton B, Stolar M, O'Malley S, Woods SW, et al. Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol. Med. 1998;28:773–788
  26. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003;116B:103–125
  27. Pompanon F, Bonin A, Bellemain E, Taberlet P. Genotyping errors: causes, consequences and solutions. Nat. Rev. 2005;6:847–859
  28. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 1990;46:222–228
  29. Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J, et al. The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample. Neurosci. Lett. 2001;297:125–128
  30. Stober G, Sprandel J, Jabs B, Pfuhlmann B, Moller-Ehrlich K, Knapp M. Family-based study of markers at the 5′-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses. Eur. Arch. Psychiatry Clin. Neurosci. 2006;256:422–427
  31. Toulopoulou T, Picchioni M, Rijsdijk F, Hua-Hall M, Ettinger U, Sham P, et al. Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch. Gen. Psychiatry. 2007;64:1348–1355
  32. van de Giessen EM, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J. Nucl. Med. 2009;50:45–52
  33. Zhang A, Xing Q, Wang L, Du J, Yu L, Lin Z, et al. Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics. 2007;8:1337–1345

PII: S0920-9964(09)00491-5

doi: 10.1016/j.schres.2009.10.004

Schizophrenia Research
Volume 116, Issue 1 , Pages 68-74 , January 2010

Article Tools

* Image Usage & Resolution